Skip to main content
. 2021 Apr 13;8:653126. doi: 10.3389/fcvm.2021.653126

Table 1.

Characteristics of the study population.

Healthy PCa PCa+ADT p
(n = 56) (n = 55) (n = 59)
Age (years) 68.77 (10.47) 69.69 (9.22) 77.90 (8.08)* <0.001
DBP (mmHg) 72.51 (8.81) 71.29 (9.66) 74.12 (6.34) NS
SBP (mmHg) 126.15 (11.03) 127.09 (10.14) 131.02 (7.19)* 0.01
HR (bpm) 73.25 (6.94) 72.22 (7.83) 75.78 (6.65)* 0.03
PSA (ng/ml) 1.18 (0.52) 1.13 (0.38) 3.23 (2.49)*+ 0.009
FSH (mUI/ml) 14.00 (12.66) 10.67 (6.48) 5.96 (7.66) *+ <0.001
LH (mUI/ml) 7.99 (12.17) 5.75 (3.57) 1.04 (3.75)*+ <0.001
Test (pg/ml) 6.22 (13.50) 14.91 (6.74) 1.89 (3.82)*+ <0.001
Estr (pg/ml) 11.62 (29.50) 32.20 (11.65) 17.93 (9.54)*+ <0.001
Glucose (mg/dl) 109.38 (25.71) 111.85 (30.06) 112.58 (32.44) NS
Uric acid (mg/dl) 6.25 (1.96) 5.60 (1.22) 5.00 (1.36)* <0.001
CRP (mg/dl) 3.08 (3.88) 3.12 (4.45) 8.29 (26.48) NS
TXA2 (pg/ml) 13.02 (8.52) 17.81 (11.06)* 26.96 (43.78) * <0.001

Values are expressed as mean with standard deviation in parentheses.

*

Statistical significance compared with healthy group.

+

Statistical significance compared with PCa group.

DBP, diastolic blood pressure; SBP systolic blood pressure; HR, heart rate; PSA, prostatic specific antigen; FSH, follicle-stimulating hormone; LH, luteinizing hormone; Test, testosterone; Estr, estradiol; CRP, C-reactive protein; TXA2, thromboxane A2.